The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
ASAP CRN Discovery Fellowship 2025, 2026Exploring the Role of Glia and T Cells in the Fatal Outcome of Vulnerable Neurons in Parkinson’s Disease
Study Rationale:
Inflammation represents a major hallmark in patients with Parkinson’s disease. However, the mechanisms connecting inflammation to the death of neurons remain...
-
ASAP CRN Discovery Fellowship 2025, 2026Can Alpha Synuclein Move Between Neurons?
Study Rationale:
Alpha synuclein is a protein that accumulates inside neurons in Parkinson’s disease. A lot of research has assume,d but never fully prove,n that this protein...
-
ASAP CRN Discovery Fellowship 2025, 2026Causal Mapping of Enhancer-Gene Networks in Parkinson’s Disease via Single-Cell Perturb-Seq and AI
Study Rationale:
Most of our DNA does not contain genes but instead acts like a complex switchboard that controls when and where genes are turned on or off. In Parkinson's...
-
ASAP CRN Discovery Fellowship 2025, 2026Network Control of Neuronal Resilience in Parkinson’s Disease
Study Rationale:
In Parkinson’s disease, damage caused by disease processes leads to the death of certain brain cells, but not all cells are equally affected. Some are more...
-
ASAP CRN Discovery Fellowship 2025, 2026The Pathogenic Role of Neuronal DNA-Sensing cGAS–STING Pathway in Alpha-Synucleinopathy
Study Rationale:
Parkinson’s Disease (PD) is characterized by neuronal aggregation of toxic alpha-synuclein (aS) protein and subsequent loss of neurons. My research found that...
-
ASAP CRN Discovery Fellowship 2025, 2026Unravelling the Impact of the Microbiome on Motor Dysfunction in Parkinson’s Disease Using Phenotypic Heterogeneity in the Pink1-/- Infection-Induced Disease Model
Study Rationale:
Development of Parkinson’s Disease (PD) involves genetic and environmental factors. Not all people with genetic risk factors for PD develop the disease...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.